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CASE REPORT
CO-INFECTION OF DENGUE VIRUS BY SEROTYPES 1 AND 4 IN PATIENT FROM  
MEDIUM SIZED CITY FROM BRAZIL
Tatiana Elias COLOMBO(1,2), Danila VEDOVELLO(1), Adriano MONDINI(3), Andrea Francesli Negri REIS(4), Amena Alcântara Ferras CURY(4),  
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SUMMARY
The natural co-infection with dengue virus can occur in highly endemic areas where different serotypes have been observed for 
many years. We report one case of DENV-1/DENV-4 co-infection in human serum detected by molecular tests. Phylogenetic analysis 
of the sequences obtained indicated the presence of genotype V and II for DENV-1 and DENV-4, respectively.
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INTRODUCTION
Dengue is a major public health issue in tropical and subtropical 
countries18,33. Dengue viruses (DENVs) belong to the Flavivirus genus, 
Flaviviridae family, and are single stranded RNA viruses, with four 
immunologically related serotypes (DENV-1 to 4) and each serotype is 
phylogenetically divided into different genotypes21,45 that have a increased 
genetic diversity as a consequence of the exponentially growing human 
circulation21,44,46.
Infection by any DENV serotype can cause different clinical diseases 
that range from an acute self-limited febrile illness, the dengue fever 
(DF) to life-threatening syndromes characterized by hemorrhagic and 
capillary leak, the dengue hemorrhagic fever and dengue shock syndrome 
(DHF/DSS)17,29. DENV infections cause 25 to 100 million cases of DF 
and 250,000 cases of DHF/DSS per year in the world. Moreover, it is 
estimated that 2.5 to 3 billion people are at risk of infection in more than 
100 countries23,49.
Historically, the state of São Paulo, Brazil, has been presenting 
dengue outbreaks since 1990 when DENV-1 was introduced in the state. 
Subsequent DENV introductions occurred in 1997 and 2002, when 
DENV-2 and DENV-3 caused huge epidemics, with an increasing number 
of mild and severe cases16,36,38.
DENV-4 had a brief circulation in the country in 1982, with a focal 
epidemic at the Northwestern region of the Brazilian Amazon. No further 
cases of DENV-4 infection had been registered in the country until 2008, 
when the virus was detected in three patients from Manaus, who had no 
international traveling history14.
DENV-4 reemerged in the country in 2010 and 2011 in the 
municipalities of Boa Vista and Cantá in Roraima State42. The virus 
then spread to different geographic regions of Brazil with cases reported 
in the northern states (Roraima, Amazonas, Pará)4, northeastern states 
(Bahia, Pernambuco, Piauí) and southeastern states (Rio de Janeiro, 
São Paulo)32,40.
São José do Rio Preto (SJRP), which is located in the northwestern 
region of São Paulo State, has been presenting an endemic circulation 
of dengue for 10 years and all four serotypes have been detected in the 
city34,40. In regards to dengue serotypes circulating in the years 2011-2012, 
527 samples were examined and 359 (68%) were positive for dengue 
virus (311 for DENV-1, 23 for DENV-2, 24 for DENV-4, 1 for DENV-1 
and DENV-4 (unpublished). In this manuscript we report a DENV-1/
DENV-4 co-infection in a patient from SJRP.
CASE REPORT
The sample RP/BR/2012/507 was obtained from a patient with DF 
in SJRP, São Paulo, Brazil, in March 12th 2012. His serum was NS1 
enzyme-linked immunosorbent assay (Bio-Rad) positive. RNA extraction 
was performed with QiAmp Viral RNA (QIAGEN, Germany). RNA was 
examined using Multiplex-Nested-PCR (M-N-PCR) to detect DENV 
1-48. The first RT-PCR was performed using Flavivirus generic primers 
based on non-structural protein (NS5). In the second PCR, nested assays 
COLOMBO, T.E.; VEDOVELLO, D.; MONDINI, A.; REIS, A.F.N.; CURY, A.A.F.; OLIVEIRA, F.H.; CRUZ, L.E.A.A.; BRONZONI, R.V.M. & NOGUEIRA, M.L. - Co-infection of dengue 
virus by serotypes 1 and 4 in patient from medium sized city from Brazil. Rev. Inst. Med. Trop. Sao Paulo, 55(4): 275-81, 2013. 
276
based on multiplex or conventional systems were used with species-
specific primers to detect and identify dengue viruses (DENV1-4). PCR 
products were loaded onto a 1.5% agarose gel and visualized under 
ultraviolet light. Amplicon sizes were determined by comparison with 
a 100 bp DNA ladder (Invitrogen). Precautions to avoid contamination 
were followed, positive and negative controls were used in all reactions, 
and the procedure was reproduced several times7. Another protocol27 
that amplifies the capsid protein (C) was also performed to confirm the 
presence of DENV-1 and DENV-4 in the same sample (Fig. 1). 
The fragments amplified by confirmatory method were purified and 
sequenced using the BigDye v3.1 (Applied Biosystems, Foster City, CA, 
USA) in an ABI3130 automatic sequencer (Applied Biosystems, Foster 
City, CA, USA). Nucleotide sequences were analyzed using the DS Gene 
2.0 Software (Accelrys, USA) and confirmed as DENV-1 and DENV-4. 
These sequences were deposited at GenBank (Accession numbers: DENV-
1 JQ950328 and DENV-4 JQ950329) (Table 1). Thirty-one sequences 
of dengue virus serotype 1 and thirty-three sequences of serotype 4 that 
correspond to the Capsid Protein gene (C) of Dengue viruses were used 
for phylogenetic analysis (Table 1). Multiple sequence alignment was 
conducted using ClustalW as implemented in BioEdit 7.1.319. 
Fragments of 365 bp (from DENV-1) and 257 bp (from DENV-4) 
with sequences that encode the capsid gene were used in the alignment. 
Using as reference the DENV-1 Mochizuki strain by Japan (Genbank 
access number AB074760.1) and DENV-4 H778494 strain for Brazil 
(Genbank access number JQ513335.1) we identify relevant amino acid 
substitutions: two substitutions were identified in polyprotein of DENV-
1, R97G (Arginine to Glycine) and M107V (Methionine to Valine), as 
for DENV-4 polyprotein, three aminoacid substitutions were identified: 
F49L (Phenylalanine to Leucine), R53F (Arginine to Phenylalanine), 
S57F (Serine to Phenylalanine) (Fig. 2A and 2B). 
The phylogenetic tree was designed with tools of MEGA 5 software 
(http://www.megasoftware.net). The statistical method was Neighbor-
Joining with Tamura-Nei model41 and the phylogeny analysis was tested 
by bootstrap method with 1000 replications. 
According to the phylogenetic tree created by genotyping of DENVs 
strains from the co-infection detected in SJRP, DENV-1 that circulated 
Fig. 1 - Electrophoresis in agarose gel showing the amplified products on two methodologies. 
PM = DNA ladder = 100 bp and 1 = Co-infection Sample RP/BR/507/2012, dengue 1 and 4 
strains. (A) Lanciotti (1992) PCR assay showing the amplicon of 482 bp and 392 bp DENV-1 
of DENV-4; (B) Bronzoni (2005) PCR assay showing the amplicon of 472 bp and 222 bp 
DENV-1 of DENV-4. 
Table 1
DENV-1 and DENV-4 sequences used for phylogenetic analysis, including serotype and genotype, isolation sites, isolation year,  
strain and GenBank accession numbers
Serotype and Genotype Genbank Accession Isolation site Strains Isolation Year
Serotype 1
D1G1 AB074760.1 Japan Mochizuki 2001
D1G1 AF180817.1 USA 16007 1999
D1G1 JN054255.1 Sri Lanka DV1_SL_2010b 2010
D1G1 GQ398255.1 Singapore SG/07K3640DK1/2008 2008
D1G1 DQ193572.1 Fujian/China Fj231/04 2004
D1G2 FJ196841.1 Guangzhou/China GD54/03 2003
D1G2 FJ196842.1 Guangzhou/China GD66/03 2003
D1G2 EF440432.1 Australia ET243 2000
D1G2 EF025110.1 China 71/02GZ 2006
D1G3 AB074761.1 Japan A88 2002
D1G3 DQ285561.1 Seychelles/ France 1480/04 2004
D1G4 U88535.1 Nauru Island Clone WestPac 1997
D1G4 M23027.1 Nauru Island Nauru Island 1994
D1G5 FJ850087.1 Northern Brazil BR/BID-V2395/2006 2006
D1G5 AF226685.2 Rio de Janeiro/Brazil Den1BR/90 2000
D1G5 AF513110.1 Curitiba/Brazil BR/01-MR 2002
D1G5 FJ850075.1 Northern Brazil BR/BID-V2381/2002 2002
D1G5 FJ850090.1 Northern Brazil BR/BID-V2398/2007 2007
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Serotype and Genotype Genbank Accession Isolation site Strains Isolation Year
Serotype 1
D1G5 FJ850084.1 Northern Brazil BR/BID-V2392/2005 2005
D1G5 JX502769.1 Brazil RR_DENV1_09007 2009
D1G5 FJ850070.1 Northern Brazil BR/BID-V2374/2000 2000
D1G5 FJ850071.1 Northern Brazil BR/BID-V2375/2000 2000
D1G5 AB519681.1 Brasilia/Brazil SB 01057805 (DF02) 2002
D1G5 FJ850081.1 Northern Brazil BR/BID-V2389/2004 2004
D1G5 HM043709.1 Brazil 55/2009ES 2009
D1G5 JN086990.1 Brazil A 2010
D1G5 JN086991.1 Brazil B 2010
Serotype 4
D4G1 FJ196850.1 Guangzhou/China GD09/1990 1990
D4G1 AF289029.1 Guangzhou/China Guangzhou B5 2000
D4G1 AF177542.1 Mindanao/Philippines Mindanao/BDJ/1995 1995
D4G1 GQ868594.1 Philippines PH/BID-V3361/1956/1956 1956
D4G2 EU854295.1 Puerto Rico US/BID-V1083/1986 1986
D4G2 GQ868582.1 Santander/Colombia CO/BID-V3409/2001 2001
D4G2 AH011968.1 Costa Rica D4.108_1996CR 1996
D4G2 JN559741.2 Boa Vista/Brazil ROR7365 2010
D4G2 JN983813.1 Boa Vista/Brazil Br246RR/2010 2010
D4G2 HQ822126.1 Roraima/Brazil Br347RR 2010
D4G2 HQ822125.1 Roraima/Brazil Br272RR 2010
D4G2 JN092557.1 Brazil SPH318527 2011
D4G2 JN712226.1 São José do Rio Preto/Brazil RP/BR/2011/131 2011
D4G2 JN712225.1 São José do Rio Preto/Brazil SJRP/BR/2011/167 2011
D4G2 JQ513335.1 Belém/Brazil BeH778494 2011
D4G2 JN092556.1 Brazil SPH319325 2011
D4G2 JN092555.1 Brazil SPH319268 2011
D4G2 JN092556.1 Brazil SPH319325 2011
D4G2 JQ513333.1 Boa Vista/ Brazil ROR7542 2010
D4G2 JQ513340.1 Boa Vista/ Brazil ROR7591 2010
D4G2 AY152252.1 San Juan/ Puerto Rico D4.69_1987 1987
D4G2 AY152084.1 San Juan/ Puerto Rico D4.84_1994 1994
D4G2 AY152056.1 San Juan/ Puerto Rico D4.17_1998 1998
D4G2 AY152196.1 San Juan/ Puerto Rico D4.28_1992 1992
D4G2 AY152336.1 San Juan/ Puerto Rico D4M.5_1982 1982
D4G2 AY152360.1 Dominica D4M.44_1981DM 1981
D4G3 HQ875339.1 Singapura SG(EHI)D4/2641Y08 2008
D4G3 GQ398256.1 Singapura SG/06K2270DK1/2005 2005
D4G3 AY618993.1 Bangkok /Thailand ThD4_0734_00 2000
Serotypes 1 to 4 using as outgroups
DENV-1 AB074760.1 Japan 2001
DENV-3 AF317645.1 Guangxi/China 2000
DENV-2 HM181971.1 São Paulo/Brazil 2008
DENV-4 AF326573.1 Dominica 2000
Table 1
DENV-1 and DENV-4 sequences used for phylogenetic analysis, including serotype and genotype, isolation sites, isolation year,  
strain and GenBank accession numbers (cont.)
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in the patient belongs to genotype V (American-African group) (Fig. 
3A) and DENV-4 belongs to genotype II (American group) (Fig. 3B). 
DISCUSSION
In this work we investigated a DENV-1/DENV-4 co-infection event in 
a patient from a public healthcare facility of SJRP (São Paulo, Brazil) in 
2012. The co-infection can worsen the patient’s condition and recovery, 
but in this case the patient doesn’t have a severe disease. 
The initial diagnosis was available by commercial ELISA assays to 
detect DENV NS1 protein in acute plasma. This assay provides additional 
dengue diagnostic tool to the existing approaches of PCR, antibody 
capture ELISA and virus isolation5,6,10,12,13,20,24,25,28. Even though NS1 is 
a sensitive methodology for the detection of DENV it should never be 
used as the only methodology for DENV detection because it doesn’t 
identify different serotypes39. 
The imunofluorescence assay is a gold standard method for Dengue 
Fig. 2 - (A) Alignment of thirty-one amino acid sequences of Capsid Protein (C) of samples obtained at Genbank and the DENV-1 sequence isolated in this work. The strain RP/BR/2012/507a 
is shown in yellow and amino acid substitutions identified are marked in green. Only amino acids are shown as distinct from the reference sample (AB074760.1). (B) Alignment of thirty-three 
amino acid sequences of Capsid Protein (C) of samples obtained at Genbank and the DENV-4 sequence isolated in this work. The strain RP/BR/2012/507b is shown in yellow and amino acid 
substitutions identified are marked in green. The amino acid substitution F49L is marked in blue. Only amino acids are shown as distinct from the reference sample (JQ513335.1).
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Diagnosis and can be used by serotype strains31. But IFA is not capable 
of detecting the co-infections with other arboviruses, furthermore, 
antibodies can be cross-reactive with Flaviviruses2,30. Therefore the 
PCR remains extremely essential for disease surveillance, especially if 
followed by nucleotide sequencing, which can lead us to a more robust 
interpretation of the epidemiological context of the infection.
In order to provide timely information for patient management, and 
early public health control of dengue outbreaks, it is important to establish 
the diagnosis of an acute dengue virus infection during the first few days 
after manifestation of clinical symptoms37.
Two different PCR assays were used in our study and both presented 
the same results. Other simultaneous Flavivirus infections, especially 
those caused by different dengue virus types, such as DENV-1 and 222,36, 
DENV-2 and 33,22,43,47,48, DENV-1 and 326, DENV-3 and DENV-414,15 have 
been reported. Hence, co-infection with distinct DENV serotypes during 
outbreaks may be expected.
The Nested-PCR used in our study8 is a suitable tool for 
detecting Flavivirus co-infections. Within a short amount of time, the 
identification of the most common Brazilian Flavivirus is possible. 
Such techniques can be applied as a rapid diagnostic tool in clinical 
samples when a Flavivirus infection is suspected and differential 
diagnosis is required34.
The nucleotide sequence was established using only one primers set 
(Lanciotti primers27 - Methodology section). This assay uses type-specific 
primers for detection and typing of dengue viruses that presented cross 
reactivity among primers27. This trend is important for diagnosis of co-
infections and also for nucleotide sequencing.
The changes in amino acids (R97G - Arginine to Glycine and 
M107V - Methionine to Valine) identified in DENV-1 C protein has not 
been reported previously. The F49L substitution perceived in DENV-4 
C protein and recognized only in other Brazilian isolates1,9,35,40 can be 
considered a genetic signature of Brazilian isolates and needs further 
investigation.
Our two phylogenetic trees present representative strains of each 
dengue serotypes (DENV-1 to 4) and they are correctly grouped according 
to what was previously described; DENV-4 was the first to diverge, 
followed by DENV-2 and a final split between DENV-1 and DENV-321. 
Our phylogenetic analysis indicates that DENV-1 and DENV-4 
viruses detected in co-infection were distributed in the genotypes V and 
Fig. 3 - (A) Neighbor-Joining phylogenetic tree of 31 sequences of DENV-1 and the sequence RP/BR/2012/507a, inferred from Capsid gene (365 bp). RP/BR/2012/507a is highlighted in gray, 
the five DENV-1 genotypes are indicated with “}” and DENV serotypes 2, 3 and 4 are used as outgroups. “D” stands for “Dengue” and “1” represents the serotype. Genotype “G” is represented 
after the serotype, with the number of the genotype. Bootstrap values are shown for key nodes and the scale bar represents 0.05 nt changes per site. (B) - Neighbor-Joining phylogenetic tree of 
33 sequences of DENV-4 and the sequence RP/BR/2012/507b, inferred from Capsid gene (257 bp). RP/BR/2012/507b is highlighted in gray, the three DENV-4 genotypes are indicated with 
“}” and DENV serotypes 1, 2 and 3 are used as outgroups. “D” stands for “Dengue” and “4” represents the serotype. Genotype “G” is represented after the serotype, with the number of the 
genotype. Bootstrap values are shown for key nodes and the scale bar represents 0.05 nt changes per site.
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II, respectively, and it also reflects the genotypes circulating in Brazil at 
the present moment11,40.
Our report demonstrates that co-infection with different serotypes of 
dengue virus can occur naturally. This study reinforces the importance 
of accurate diagnosis that really elucidate the origin of infection and 
emphasizes the RT-PCR has the advantage to be used for molecular 
characterization, when followed by nucleotide sequencing and 
bioinformatics analysis. 
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RESUMO
Co-infecção por vírus dengue, sorotipos 1 e 4, em paciente de 
cidade de porte médio no Brasil
A co-infecção por dengue vírus pode ocorrer em áreas com circulação 
endêmica, nas quais diferentes sorotipos vêm circulando durante muitos 
anos. Neste trabalho relatamos um caso de co-infecção por DENV-1/
DENV-4 em soro humano, detectado por testes moleculares. Análises 
filogenéticas das sequências obtidas indicaram a presença do genótipo 
V e II de DENV-1 e DENV-4, respectivamente.
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